Close Menu

NEW YORK – Waters reported on Tuesday that its first quarter revenues fell 10 percent year over year, as the company saw weak sales in China due to the SARS-CoV-2 pandemic.

Waters posted revenues of $464.9 million for the quarter compared to $513.9 million in Q1 2019, below the average Wall Street estimate of $488.5 million.

Currency translation decreased sales growth by around 2 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.